2026 NPPES data Corneal and Contact Management Optometrist NPI 1144484858 O.D.
Verify on CMS →

CHIKE MORDI, O.D.

Corneal and Contact Management Optometrist in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
768
Medicare Part D claims · 188 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
34%
generic claims · 66% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

CHIKE MORDI, O.D. filed 768 Medicare Part D claims in 2023 as a Corneal and Contact Management Optometrist in HOUSTON, Texas, prescribing 34% generic.

768
Part D claims, 2023
34%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHIKE MORDI, O.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

768 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about CHIKE MORDI, O.D.?

Quality data not reported

NPI registry status

Active

Issued 07/11/2008

NPI 1144484858

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

768 227% vs specialty avg

2023 prescription claims

Specialty avg: 235

Specialty distribution in Texas

How Corneal and Contact Management Optometrist compares to other specialties among Texas providers

Texas providers

Corneal and Contact Management Optometrist share within Texas

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Corneal and Contact Management Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Corneal and Contact Management Optometrist ABMS/AOA estimate

Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHIKE MORDI, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 4899 GRIGGS RD, HOUSTON, TX, 77021, with a listed phone of (713) 748-5000. NPI 1144484858 was issued on 07/11/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MORDI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 768 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $254K in drug spend, split 66% brand-name and 34% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4899 GRIGGS RD
HOUSTON, TX 77021

Provider Details

NPI 1144484858
Specialty Corneal and Contact Management Optometrist
Credentials O.D.
Gender Male
NPI Issued 07/11/2008

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to CHIKE MORDI, O.D.. To verify CHIKE MORDI, O.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

CHIKE MORDI, O.D. — brand share 66.0%
Specialty average (est.)

66% brand-name claims vs 34% generic, on 768 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

768
Total Claims
$254K
Total Drug Cost
188
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,093
Total Day Supply
31,414
Brand vs Generic
66% brand / 34% generic
Brand Drug Cost
$232K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
67.3 years
Avg HCC Risk Score
2.07
Gender Split
68% female / 32% male
Age Distribution
<65: 58, 65-74: 91, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHIKE MORDI, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Restasis
Cyclosporine
228
Latanoprost
179
Difluprednate
40
Combigan
Brimonidine Tartrate/Timolol
27
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
27
Dorzolamide Hcl
23
Cyclosporine
22
Brimonidine Tartrate
21
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
21
Xiidra
Lifitegrast
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How CHIKE MORDI, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

CHIKE MORDI, O.D.'s 768 claims are above the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as MORDI.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHIKE MORDI, O.D.'s specialty?
CHIKE MORDI, O.D. specializes in Corneal and Contact Management Optometrist and practices in HOUSTON, Texas. Credentials: O.D..
How much does CHIKE MORDI, O.D. prescribe under Medicare Part D?
In 2023, CHIKE MORDI, O.D. wrote 768 Medicare Part D claims totaling $254K in drug costs for 188 beneficiaries.
Where is CHIKE MORDI, O.D. located?
CHIKE MORDI, O.D. is located at 4899 GRIGGS RD, HOUSTON, TX, 77021. Phone: (713) 748-5000.
What is CHIKE MORDI, O.D.'s NPI number?
CHIKE MORDI, O.D.'s National Provider Identifier (NPI) is 1144484858, issued on 07/11/2008.
Does CHIKE MORDI, O.D. prescribe more brand-name or generic drugs?
CHIKE MORDI, O.D.'s prescribing is 66% brand-name and 34% generic drugs by claim count, with $232K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does CHIKE MORDI, O.D. prescribe most often?
Based on 2023 Medicare Part D data, CHIKE MORDI, O.D.'s most frequently prescribed drugs include Restasis, Latanoprost, Difluprednate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHIKE MORDI, O.D. accept Medicare?
CHIKE MORDI, O.D. appears in CMS Medicare data with 768 Part D claims and 188 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHIKE MORDI, O.D.'s credentials?
CHIKE MORDI, O.D.'s NPI is 1144484858 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology